Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization

To report a patient with juxtapapillary choroidal osteoma (CO) with serous retinal detachment (SRD) not associated with choroidal neovascularization (CNV) who was successfully treated with a single intravitreal injection of bevacizumab. A 20-year-old woman presented with decreased vision in her righ...

Full description

Bibliographic Details
Main Authors:	Najafabadi, Farhad Fazel, Hendimarjan, Seyyed Moien, Zarrin, Yasaman, Najafabadi, Mohammadreza Fazel
Format:	Online
Language:	English
Published:	Medknow Publications & Media Pvt Ltd 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795400/

id	pubmed-4795400
recordtype	oai_dc
spelling	pubmed-47954002016-04-05 Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization Najafabadi, Farhad Fazel Hendimarjan, Seyyed Moien Zarrin, Yasaman Najafabadi, Mohammadreza Fazel Case Report To report a patient with juxtapapillary choroidal osteoma (CO) with serous retinal detachment (SRD) not associated with choroidal neovascularization (CNV) who was successfully treated with a single intravitreal injection of bevacizumab. A 20-year-old woman presented with decreased vision in her right eye. Ultrasonography, fundus autofluorescence, fluorescein angiography (FA) and optical coherence tomography (OCT) were performed. She was diagnosed with juxtapapillary CO with SRD in the absence of CNV. The treatment involved a single intravitreal injection of bevacizumab. Visual acuity (VA) was 20/100 pre-injection which was dramatically improved to 20/20 one week after the injection without any additional treatment. Fundus examination and OCT one week after the injection revealed complete absorption of the subretinal fluid (SRF) in the macula. Eighteen months after the injection, vision remained stable and she did not show re-accumulation of SRF in her right eye. Intravitreal injection of bevacizumab may be effective in managing CO associated with SRF without CNV. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4795400/ /pubmed/27051495 http://dx.doi.org/10.4103/2008-322X.176905 Text en Copyright: © Journal of Ophthalmic and Vision Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Najafabadi, Farhad Fazel Hendimarjan, Seyyed Moien Zarrin, Yasaman Najafabadi, Mohammadreza Fazel
spellingShingle	Najafabadi, Farhad Fazel Hendimarjan, Seyyed Moien Zarrin, Yasaman Najafabadi, Mohammadreza Fazel Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
author_facet	Najafabadi, Farhad Fazel Hendimarjan, Seyyed Moien Zarrin, Yasaman Najafabadi, Mohammadreza Fazel
author_sort	Najafabadi, Farhad Fazel
title	Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
title_short	Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
title_full	Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
title_fullStr	Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
title_full_unstemmed	Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
title_sort	intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
description	To report a patient with juxtapapillary choroidal osteoma (CO) with serous retinal detachment (SRD) not associated with choroidal neovascularization (CNV) who was successfully treated with a single intravitreal injection of bevacizumab. A 20-year-old woman presented with decreased vision in her right eye. Ultrasonography, fundus autofluorescence, fluorescein angiography (FA) and optical coherence tomography (OCT) were performed. She was diagnosed with juxtapapillary CO with SRD in the absence of CNV. The treatment involved a single intravitreal injection of bevacizumab. Visual acuity (VA) was 20/100 pre-injection which was dramatically improved to 20/20 one week after the injection without any additional treatment. Fundus examination and OCT one week after the injection revealed complete absorption of the subretinal fluid (SRF) in the macula. Eighteen months after the injection, vision remained stable and she did not show re-accumulation of SRF in her right eye. Intravitreal injection of bevacizumab may be effective in managing CO associated with SRF without CNV.
publisher	Medknow Publications & Media Pvt Ltd
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795400/
_version_	1613552998552698880

Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization

Similar Items